Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Introduction of Genetically-Modified CD3ζ Improves Proliferation and Persistence of Antigen-specific CTLs.

Miyao K, Terakura S, Okuno S, Julamanee J, Watanabe K, Hamana H, Kishi H, Sakemura R, Koyama D, Goto T, Nishida T, Murata M, Kiyoi H.

Cancer Immunol Res. 2018 Apr 13. pii: canimm.0538.2017. doi: 10.1158/2326-6066.CIR-17-0538. [Epub ahead of print]

PMID:
29653982
2.

[MonoMAC syndrome patient developing myelodysplastic syndrome following persistent EBV infection].

Yamamoto H, Hattori H, Takagi E, Morishita T, Ishikawa Y, Terakura S, Nishida T, Ito Y, Murata M, Kiyoi H.

Rinsho Ketsueki. 2018;59(3):315-322. doi: 10.11406/rinketsu.59.315. Japanese.

PMID:
29618691
3.

Efficacy and safety of autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: A study protocol for a multicenter exploratory prospective study (Auto-Ph17 study).

Nishiwaki S, Sugiura I, Miyata Y, Saito S, Sawa M, Nishida T, Miyamura K, Kuwatsuka Y, Kohno A, Yuge M, Kasai M, Iida H, Kurahashi S, Osaki M, Goto T, Terakura S, Murata M, Nishikawa H, Kiyoi H.

Medicine (Baltimore). 2017 Dec;96(52):e9568. doi: 10.1097/MD.0000000000009568.

4.

The activated conformation of integrin β7 is a novel multiple myeloma-specific target for CAR T cell therapy.

Hosen N, Matsunaga Y, Hasegawa K, Matsuno H, Nakamura Y, Makita M, Watanabe K, Yoshida M, Satoh K, Morimoto S, Fujiki F, Nakajima H, Nakata J, Nishida S, Tsuboi A, Oka Y, Manabe M, Ichihara H, Aoyama Y, Mugitani A, Nakao T, Hino M, Uchibori R, Ozawa K, Baba Y, Terakura S, Wada N, Morii E, Nishimura J, Takeda K, Oji Y, Sugiyama H, Takagi J, Kumanogoh A.

Nat Med. 2017 Dec;23(12):1436-1443. doi: 10.1038/nm.4431. Epub 2017 Nov 6.

PMID:
29106400
5.

High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotype.

Koyama D, Murata M, Hanajiri R, Okuno S, Kamoshita S, Julamanee J, Takagi E, Hirano D, Miyao K, Sakemura R, Goto T, Hayakawa F, Seto A, Ozawa Y, Miyamura K, Terakura S, Nishida T, Kiyoi H.

PLoS One. 2017 Sep 25;12(9):e0185213. doi: 10.1371/journal.pone.0185213. eCollection 2017.

6.

Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.

Tawara I, Kageyama S, Miyahara Y, Fujiwara H, Nishida T, Akatsuka Y, Ikeda H, Tanimoto K, Terakura S, Murata M, Inaguma Y, Masuya M, Inoue N, Kidokoro T, Okamoto S, Tomura D, Chono H, Nukaya I, Mineno J, Naoe T, Emi N, Yasukawa M, Katayama N, Shiku H.

Blood. 2017 Nov 2;130(18):1985-1994. doi: 10.1182/blood-2017-06-791202. Epub 2017 Aug 31.

PMID:
28860210
7.

GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia.

Terakura S, Kuwatsuka Y, Yamasaki S, Wake A, Kanda J, Inamoto Y, Mizuta S, Yamaguchi T, Uchida N, Kouzai Y, Aotsuka N, Ogawa H, Kanamori H, Nishiwaki K, Miyakoshi S, Onizuka M, Amano I, Fukuda T, Ichinohe T, Atsuta Y, Murata M, Teshima T.

Bone Marrow Transplant. 2017 Sep;52(9):1261-1267. doi: 10.1038/bmt.2017.116. Epub 2017 Jun 12.

PMID:
28604665
8.

Phase II study of intrabone single unit cord blood transplantation for hematological malignancies.

Murata M, Maeda Y, Masuko M, Onishi Y, Endo T, Terakura S, Ishikawa Y, Iriyama C, Ushijima Y, Goto T, Fujii N, Tanimoto M, Kobayashi H, Shibasaki Y, Fukuhara N, Inamoto Y, Suzuki R, Kodera Y, Matsushita T, Kiyoi H, Naoe T, Nishida T.

Cancer Sci. 2017 Aug;108(8):1634-1639. doi: 10.1111/cas.13291. Epub 2017 Jun 29.

9.

Malignant lymphoma with cardiac involvement.

Terakura S, Onji M, Iriyama C, Goto T, Ushijima Y, Shimada K, Ishikawa Y, Nishida T, Hayakawa F, Murata M, Kiyoi H.

Rinsho Ketsueki. 2017;58(3):239-242. doi: 10.11406/rinketsu.58.239. Japanese.

PMID:
28381692
10.

Increase of bone marrow macrophages and CD8+ T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation.

Kawashima N, Terakura S, Nishiwaki S, Koyama D, Ozawa Y, Ito M, Miyamura K.

Bone Marrow Transplant. 2017 Aug;52(8):1164-1170. doi: 10.1038/bmt.2017.58. Epub 2017 Apr 3.

PMID:
28368374
11.

Impact of T-cell chimerism on relapse after cord blood transplantation for hematological malignancies: Nagoya Blood and Marrow Transplantation Group study.

Yokohata E, Kuwatsuka Y, Ohashi H, Terakura S, Kawashima N, Seto A, Kurahashi S, Ozawa Y, Goto T, Imahashi N, Nishida T, Miyao K, Sakemura R, Kato T, Sawa M, Kohno A, Sao H, Iida H, Kiyoi H, Naoe T, Miyamura K, Murata M.

Bone Marrow Transplant. 2017 Apr;52(4):612-614. doi: 10.1038/bmt.2016.323. Epub 2017 Jan 9. No abstract available.

PMID:
28067879
12.

Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil.

Terakura S, Wake A, Inamoto Y, Murata M, Sakai R, Yamaguchi T, Takahashi S, Uchida N, Onishi Y, Ohashi K, Ozawa Y, Kanamori H, Yamaguchi H, Fukuda T, Ichinohe T, Takanashi M, Atsuta Y, Teshima T.

Bone Marrow Transplant. 2017 Mar;52(3):423-430. doi: 10.1038/bmt.2016.255. Epub 2016 Dec 12.

PMID:
27941766
13.

Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation.

Kanda J, Morishima Y, Terakura S, Wake A, Uchida N, Takahashi S, Ono Y, Onishi Y, Kanamori H, Aotsuka N, Ozawa Y, Ogawa H, Sakura T, Ohashi K, Ichinohe T, Kato K, Atsuta Y, Teshima T, Murata M.

Leukemia. 2017 Mar;31(3):663-668. doi: 10.1038/leu.2016.288. Epub 2016 Oct 17.

PMID:
27748373
14.

Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.

Goto T, Nishida T, Takagi E, Miyao K, Koyama D, Sakemura R, Hanajiri R, Watanabe K, Imahashi N, Terakura S, Murata M, Kiyoi H.

J Immunother. 2016 Oct;39(8):306-15. doi: 10.1097/CJI.0000000000000136.

PMID:
27548033
15.

A Tet-On Inducible System for Controlling CD19-Chimeric Antigen Receptor Expression upon Drug Administration.

Sakemura R, Terakura S, Watanabe K, Julamanee J, Takagi E, Miyao K, Koyama D, Goto T, Hanajiri R, Nishida T, Murata M, Kiyoi H.

Cancer Immunol Res. 2016 Aug;4(8):658-68. doi: 10.1158/2326-6066.CIR-16-0043. Epub 2016 Jun 21.

16.

Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia.

Terakura S, Atsuta Y, Tsukada N, Kobayashi T, Tanaka M, Kanda J, Najima Y, Fukuda T, Uchida N, Takahashi S, Nagamura-Inoue T, Morishima Y, Miyamura K; Japan Society for Hematopoietic Cell Transplantation.

Biol Blood Marrow Transplant. 2016 Feb;22(2):330-338. doi: 10.1016/j.bbmt.2015.10.006. Epub 2015 Oct 22.

17.

Integration of humoral and cellular HLA-specific immune responses in cord blood allograft rejection.

Hanajiri R, Murata M, Sugimoto K, Murase M, Sakemura R, Goto T, Watanabe K, Imahashi N, Terakura S, Ohashi H, Akatsuka Y, Kurahashi S, Miyamura K, Kiyoi H, Nishida T, Naoe T.

Bone Marrow Transplant. 2015 Sep;50(9):1187-94. doi: 10.1038/bmt.2015.119. Epub 2015 Jun 1.

PMID:
26030050
18.

Cutaneous macrophage infiltration in acute GvHD.

Terakura S, Martin PJ, Shulman HM, Storer BE.

Bone Marrow Transplant. 2015 Aug;50(8):1135-7. doi: 10.1038/bmt.2015.114. Epub 2015 May 11. No abstract available.

PMID:
25961771
19.

Chimerism status after unrelated donor bone marrow transplantation with fludarabine-melphalan conditioning is affected by the melphalan dose and is predictive of relapse.

Imahashi N, Ohashi H, Terakura S, Miyao K, Sakemura R, Kato T, Sawa M, Yokohata E, Kurahashi S, Ozawa Y, Nishida T, Kiyoi H, Watamoto K, Kohno A, Kasai M, Kato C, Iida H, Naoe T, Miyamura K, Murata M; Nagoya Blood and Marrow Transplantation Group.

Ann Hematol. 2015 Jul;94(7):1139-48. doi: 10.1007/s00277-015-2312-4. Epub 2015 Feb 15.

PMID:
25680895
20.

Simple and efficient generation of virus-specific T cells for adoptive therapy using anti-4-1BB antibody.

Imahashi N, Nishida T, Goto T, Terakura S, Watanabe K, Hanajiri R, Sakemura R, Imai M, Kiyoi H, Naoe T, Murata M.

J Immunother. 2015 Feb-Mar;38(2):62-70. doi: 10.1097/CJI.0000000000000069.

PMID:
25658615
21.

Target antigen density governs the efficacy of anti-CD20-CD28-CD3 ζ chimeric antigen receptor-modified effector CD8+ T cells.

Watanabe K, Terakura S, Martens AC, van Meerten T, Uchiyama S, Imai M, Sakemura R, Goto T, Hanajiri R, Imahashi N, Shimada K, Tomita A, Kiyoi H, Nishida T, Naoe T, Murata M.

J Immunol. 2015 Feb 1;194(3):911-20. doi: 10.4049/jimmunol.1402346. Epub 2014 Dec 17.

22.

Comparison of cord blood transplantation with unrelated bone marrow transplantation in patients older than fifty years.

Tanaka M, Miyamura K, Terakura S, Imai K, Uchida N, Ago H, Sakura T, Eto T, Ohashi K, Fukuda T, Taniguchi S, Mori S, Nagamura-Inoue T, Atsuta Y, Okamoto S.

Biol Blood Marrow Transplant. 2015 Mar;21(3):517-25. doi: 10.1016/j.bbmt.2014.11.685. Epub 2014 Dec 8.

23.

Protein encoded by oncogene 6b from Agrobacterium tumefaciens has a reprogramming potential and histone chaperone-like activity.

Ishibashi N, Kitakura S, Terakura S, Machida C, Machida Y.

Front Plant Sci. 2014 Oct 28;5:572. doi: 10.3389/fpls.2014.00572. eCollection 2014. Review.

24.

Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functions.

Nishiwaki S, Nakayama T, Murata M, Nishida T, Terakura S, Saito S, Kato T, Mizuno H, Imahashi N, Seto A, Ozawa Y, Miyamura K, Ito M, Takeshita K, Kato H, Toyokuni S, Nagao K, Ueda R, Naoe T.

PLoS One. 2014 May 7;9(5):e96252. doi: 10.1371/journal.pone.0096252. eCollection 2014.

25.

Successful unrelated cord blood transplantation for adult acquired aplastic anemia using reduced intensity conditioning without ATG.

Terakura S, Nishida T, Inamoto Y, Ohashi H, Naoe T, Murata M.

Immunol Lett. 2014 Jul;160(1):99-101. doi: 10.1016/j.imlet.2014.01.013. Epub 2014 Jan 29. No abstract available.

PMID:
24487060
26.

Identification of a novel HLA-A*24:02-restricted adenovirus serotype 11-specific CD8+ T-cell epitope for adoptive immunotherapy.

Imahashi N, Nishida T, Ito Y, Kawada J, Nakazawa Y, Toji S, Suzuki S, Terakura S, Kato T, Murata M, Naoe T.

Mol Immunol. 2013 Dec;56(4):399-405. doi: 10.1016/j.molimm.2013.05.232. Epub 2013 Aug 1.

PMID:
23911395
27.

Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematological malignancies.

Yasuda T, Suzuki R, Ishikawa Y, Terakura S, Inamoto Y, Yanada M, Nagai H, Ozawa Y, Ozeki K, Atsuta Y, Emi N, Naoe T.

Int J Infect Dis. 2013 Jun;17(6):e385-90. doi: 10.1016/j.ijid.2012.12.005. Epub 2013 Jan 11.

28.

Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction.

Kanda J, Ichinohe T, Kato S, Uchida N, Terakura S, Fukuda T, Hidaka M, Ueda Y, Kondo T, Taniguchi S, Takahashi S, Nagamura-Inoue T, Tanaka J, Atsuta Y, Miyamura K, Kanda Y; Donor/Source Working Group and HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Leukemia. 2013 Feb;27(2):286-94. doi: 10.1038/leu.2012.203. Epub 2012 Jul 18.

PMID:
22806066
29.

Phase II study of dose-modified busulfan by real-time targeting in allogeneic hematopoietic stem cell transplantation for myeloid malignancy.

Kuwatsuka Y, Kohno A, Terakura S, Saito S, Shimada K, Yasuda T, Inamoto Y, Miyamura K, Sawa M, Murata M, Karasuno T, Taniguchi S, Nagafuji K, Atsuta Y, Suzuki R, Fukumoto M, Naoe T, Morishita Y; Nagoya Blood and Marrow Transplantation Group.

Cancer Sci. 2012 Sep;103(9):1688-94. doi: 10.1111/j.1349-7006.2012.02342.x. Epub 2012 Jul 16.

30.

Escape of leukemia blasts from HLA-specific CTL pressure in a recipient of HLA one locus-mismatched bone marrow transplantation.

Kato T, Terakura S, Murata M, Sugimoto K, Murase M, Iriyama C, Tomita A, Abe A, Suzuki M, Nishida T, Naoe T.

Cell Immunol. 2012 Mar-Apr;276(1-2):75-82. doi: 10.1016/j.cellimm.2012.03.011. Epub 2012 Apr 11.

31.

Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells.

Terakura S, Yamamoto TN, Gardner RA, Turtle CJ, Jensen MC, Riddell SR.

Blood. 2012 Jan 5;119(1):72-82. doi: 10.1182/blood-2011-07-366419. Epub 2011 Oct 26.

32.

Virus-associated hemophagocytic syndrome caused by pandemic swine-origin influenza A (H1N1) in a patient after unrelated bone marrow transplantation.

Katsumi A, Nishida T, Murata M, Terakura S, Shimada K, Saito S, Kobayashi M, Kodaira A, Shibata S, Oda I, Yagi T, Kiyoi H, Matsushita T, Kojima T, Naoe T.

J Clin Exp Hematop. 2011;51(1):63-5. No abstract available.

33.

A prospective dose-finding trial using a modified continual reassessment method for optimization of fludarabine plus melphalan conditioning for marrow transplantation from unrelated donors in patients with hematopoietic malignancies.

Terakura S, Atsuta Y, Sawa M, Ohashi H, Kato T, Nishiwaki S, Imahashi N, Yasuda T, Murata M, Miyamura K, Suzuki R, Naoe T, Ito T, Morishita Y; Nagoya Blood and Marrow Transplantation Group.

Ann Oncol. 2011 Aug;22(8):1865-71. doi: 10.1093/annonc/mdq673. Epub 2011 Feb 2.

PMID:
21289367
34.

Impact of post-transplant imatinib administration on Philadelphia chromosome-positive acute lymphoblastic leukaemia.

Nishiwaki S, Miyamura K, Kato C, Terakura S, Ohashi K, Sakamaki H, Nakao S, Harigae H, Kodera Y.

Anticancer Res. 2010 Jun;30(6):2415-8.

PMID:
20651401
35.

Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission.

Nishiwaki S, Terakura S, Yasuda T, Imahashi N, Sao H, Iida H, Kamiya Y, Niimi K, Morishita Y, Kohno A, Yokozawa T, Ohashi H, Sawa M, Kodera Y, Miyamura K.

Int J Hematol. 2010 Apr;91(3):419-25. doi: 10.1007/s12185-010-0509-9. Epub 2010 Feb 10.

PMID:
20146028
36.

CTL clones isolated from an HLA-Cw-mismatched bone marrow transplant recipient with acute graft-versus-host disease.

Sugimoto K, Murata M, Terakura S, Naoe T.

J Immunol. 2009 Nov 1;183(9):5991-8. doi: 10.4049/jimmunol.0804310. Epub 2009 Oct 7.

37.

Impact of the basal metabolic ratio in predicting early deaths after allogeneic stem cell transplantation.

Nishiwaki S, Miyamura K, Seto A, Watanabe K, Yanagisawa M, Imahashi N, Shimba M, Yasuda T, Kuwatsuka Y, Oba T, Terakura S, Kodera Y.

Am J Hematol. 2009 Sep;84(9):608-11. doi: 10.1002/ajh.21486.

38.

Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease.

Nishiwaki S, Terakura S, Ito M, Goto T, Seto A, Watanabe K, Yanagisawa M, Imahashi N, Tsukamoto S, Shimba M, Ozawa Y, Miyamura K.

Blood. 2009 Oct 1;114(14):3113-6. doi: 10.1182/blood-2009-03-209635. Epub 2009 Jul 30.

39.

Donor single nucleotide polymorphism in the CCR9 gene affects the incidence of skin GVHD.

Inamoto Y, Murata M, Katsumi A, Kuwatsuka Y, Tsujimura A, Ishikawa Y, Sugimoto K, Onizuka M, Terakura S, Nishida T, Kanie T, Taji H, Iida H, Suzuki R, Abe A, Kiyoi H, Matsushita T, Miyamura K, Kodera Y, Naoe T.

Bone Marrow Transplant. 2010 Feb;45(2):363-9. doi: 10.1038/bmt.2009.131. Epub 2009 Jun 15.

PMID:
19525985
40.

Eosinophilia predicts better overall survival after acute graft-versus-host-disease.

Imahashi N, Miyamura K, Seto A, Watanabe K, Yanagisawa M, Nishiwaki S, Shinba M, Yasuda T, Kuwatsuka Y, Terakura S, Kodera Y.

Bone Marrow Transplant. 2010 Feb;45(2):371-7. doi: 10.1038/bmt.2009.135. Epub 2009 Jun 15.

PMID:
19525984
41.

Busulfex (i.v. BU) and CY regimen before SCT: Japanese-targeted phase II pharmacokinetics combined study.

Kim SW, Mori SI, Tanosaki R, Fukuda T, Kami M, Sakamaki H, Yamashita T, Kodera Y, Terakura S, Taniguchi S, Miyakoshi S, Usui N, Yano S, Kawano Y, Nagatoshi Y, Harada M, Morishima Y, Okamoto S, Saito AM, Ohashi Y, Ueda R, Takaue Y.

Bone Marrow Transplant. 2009 Apr;43(8):611-7. doi: 10.1038/bmt.2008.372. Epub 2008 Nov 17.

PMID:
19011665
42.

Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature review.

Murata M, Ishikawa Y, Ohashi H, Terakura S, Ozeki K, Kiyoi H, Naoe T.

Int J Hematol. 2008 Jul;88(1):111-115. doi: 10.1007/s12185-008-0094-3. Epub 2008 May 10. Review.

PMID:
18470599
43.

Interaction between Agrobacterium tumefaciens oncoprotein 6b and a tobacco nucleolar protein that is homologous to TNP1 encoded by a transposable element of Antirrhinum majus.

Kitakura S, Terakura S, Yoshioka Y, Machida C, Machida Y.

J Plant Res. 2008 Jul;121(4):425-33. doi: 10.1007/s10265-008-0160-1. Epub 2008 May 8.

PMID:
18463947
44.

Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype.

Sugimoto K, Murata M, Onizuka M, Inamoto Y, Terakura S, Kuwatsuka Y, Oba T, Miyamura K, Kodera Y, Naoe T.

Int J Hematol. 2008 Jun;87(5):451-458. doi: 10.1007/s12185-008-0061-z. Epub 2008 Mar 26.

PMID:
18365141
45.

Potential role of a mismatched HLA-specific CTL clone developed pre-transplant in graft rejection following cord blood transplantation.

Narimatsu H, Murata M, Terakura S, Sugimoto K, Naoe T.

Biol Blood Marrow Transplant. 2008 Apr;14(4):397-402. doi: 10.1016/j.bbmt.2008.01.001. Epub 2008 Feb 14.

46.

Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults.

Sugimoto K, Narimatsu H, Kawase T, Iida H, Watanabe M, Kohno A, Kuwatsuka Y, Uchida T, Hamaguchi M, Terakura S, Naoe T, Matsuo K, Murata M, Sawa M, Miyamura K, Morishita Y; Nagoya Blood and Marrow Transplantation Group (NBMTG).

Bone Marrow Transplant. 2008 Apr;41(8):729-36. doi: 10.1038/sj.bmt.1705959. Epub 2008 Jan 7.

PMID:
18176617
47.

Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.

Inamoto Y, Suzuki R, Kuwatsuka Y, Yasuda T, Takahashi T, Tsujimura A, Sugimoto K, Oba T, Terakura S, Atsuta Y, Murata M, Ito M, Kodera Y, Miyamura K.

Biol Blood Marrow Transplant. 2008 Jan;14(1):43-9. Epub 2007 Dec 3.

48.

An oncoprotein from the plant pathogen agrobacterium has histone chaperone-like activity.

Terakura S, Ueno Y, Tagami H, Kitakura S, Machida C, Wabiko H, Aiba H, Otten L, Tsukagoshi H, Nakamura K, Machida Y.

Plant Cell. 2007 Sep;19(9):2855-65. Epub 2007 Sep 21. Erratum in: Plant Cell. 2007 Nov;19(11):3832.

49.

Successful nonmyeloablative bone marrow transplantation for leukocyte adhesion deficiency type I from an unrelated donor.

Tokunaga M, Miyamura K, Ohashi H, Ishiwada N, Terakura S, Ikeguchi M, Kuwatsuka Y, Inamoto Y, Oba T, Tsuchiya S, Kodera Y.

Int J Hematol. 2007 Jul;86(1):91-5.

PMID:
17675274
50.

Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell doses.

Terakura S, Azuma E, Murata M, Kumamoto T, Hirayama M, Atsuta Y, Kodera Y, Yazaki M, Naoe T, Kato K.

Biol Blood Marrow Transplant. 2007 Jul;13(7):822-30. Epub 2007 Apr 30.

Supplemental Content

Loading ...
Support Center